Amicus Therapeutics (FOLD) – Hot FDA News
-
Amicus Therapeutics (FOLD) Announces FDA Deferral of Action on Filing for AT-GAA in Late-onset Pompe Disease
-
Amicus' (FOLD) AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase
-
-
-
-
-
-
-
-
-
Back to FOLD Stock Lookup